Global Medical Hemostatic Agents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Medical Hemostatic Agents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Mechanical agents (also called passive substances) are generally thought to be the most effective for small amounts of bleeding and they create a barrier to stop blood flow and a surface that permits blood to clot more rapidly.

According to our (Global Info Research) latest study, the global Medical Hemostatic Agents market size was valued at US$ 3812 million in 2023 and is forecast to a readjusted size of USD 5442 million by 2030 with a CAGR of 5.3% during review period.

North America is the largest consumption region, with a more than 40% market share. Then Europe is the second largest consumption region with the market share of about 30%. J&J, Baxter, BD, Gelita, Pfizer, B Braun are the leaders of the global Medical Hemostatic Agents market, and they hold more than 65% market share. Medical Hemostatic Agents is widely used in Hospital, Surgical Centers and other field. The most proportion of Medical Hemostatic Agents is Hospital, and the sales proportion is about 65%. The classification of Medical Hemostatic Agents includes Gelation Hemostats, Combination Hemostats and Others Type. The proportion of Combination Hemostats and Gelation Hemostats in 2019 is more than 50%.

This report is a detailed and comprehensive analysis for global Medical Hemostatic Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Medical Hemostatic Agents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Medical Hemostatic Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Medical Hemostatic Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Medical Hemostatic Agents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Medical Hemostatic Agents

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Medical Hemostatic Agents market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include J&J, Baxter, BD, Gelita, Pfizer, B Braun, CSL Behring, Ferrosan Medical Devices, Advance Medical Solution, Medtronic, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Medical Hemostatic Agents market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Gelation Hemostats
Combination Hemostats
Others

Market segment by Application
Hospitals
Surgical Centers
Others

Major players covered
J&J
Baxter
BD
Gelita
Pfizer
B Braun
CSL Behring
Ferrosan Medical Devices
Advance Medical Solution
Medtronic
Z-Medica
Marine Polymer
Equimedical
CryoLife

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Medical Hemostatic Agents product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Medical Hemostatic Agents, with price, sales quantity, revenue, and global market share of Medical Hemostatic Agents from 2019 to 2024.

Chapter 3, the Medical Hemostatic Agents competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Medical Hemostatic Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Medical Hemostatic Agents market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Hemostatic Agents.

Chapter 14 and 15, to describe Medical Hemostatic Agents sales channel, distributors, customers, research findings and conclusion.